PDF Cover

DNA and RNA Banking Services Market

DNA and RNA Banking Services Market

The market for DNA and RNA Banking Services was estimated at $7.9 billion in 2024; it is anticipated to increase to $11.0 billion by 2030, with projections indicating growth to around $14.6 billion by 2035.

Report ID:DS1804064
Author:Debadatta Patel - Senior Consultant
Published Date:July 2025
Datatree
Life Science
Biotechnology
DNA and RNA Banking Services
Share
Report Summary
Table of Contents
Methodology
Market Data

Global DNA and RNA Banking Services Market Outlook

Revenue, 2024

$7.9B

Forecast, 2034

$13.8B

CAGR, 2024 - 2034

5.7%
The DNA and RNA Banking Services industry revenue is expected to be around $8.4 billion in 2025 and expected to showcase growth with 5.7% CAGR between 2025 and 2034. The substantial expansion in the DNA and RNA Banking Services sector is mainly fueled by the growing importance of research in diagnosing and treating diseases​. The continuous importance of the market is underlined by the increasing need for personalized medicine​. The increase in genetic disorders​ and the increased focus on preserving genetic material for future applications​. Technological advancements in biobanking and increased funding, for genomics research are also significant factors driving market growth​.

DNA and RNA banking services encompass the gathering, handling, preserving and dispersal of DNA and RNA specimens. These services play a role in multiple fields such as healthcare, farming and forensic science. Important aspects of these services consist of top notch sample conservation, rigorous quality assurance protocols and safe storage infrastructures. Primary uses span from investigations, medication exploration and innovation, to illness detection and therapy.

DNA and RNA Banking Services market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034

Market Key Insights

  • The DNA and RNA Banking Services market is projected to grow from $7.9 billion in 2024 to $13.8 billion in 2034. This represents a CAGR of 5.7%, reflecting rising demand across Genomic Research, Forensic Science and Personalized Medicine.
  • Thermo Fisher Scientific Inc., QIAGEN N.V., Brooks Automation Inc. are among the leading players in this market, shaping its competitive landscape.
  • U.S. and Germany are the top markets within the DNA and RNA Banking Services market and are expected to observe the growth CAGR of 3.7% to 5.5% between 2024 and 2030.
  • Emerging markets including India, Brazil and South Africa are expected to observe highest growth with CAGR ranging between 6.6% to 7.9%.
  • Transition like Technological Advancements is expected to add $800.0 million to the Dna And Rna Banking Services market growth by 2030
  • The DNA and RNA Banking Services market is set to add $5.9 billion between 2024 and 2034, with manufacturer targeting Pharmaceutical Companies & Research Institutes Applications projected to gain a larger market share.
  • With Advancements in genomic research, and Increasing prevalence of genetic disorders, DNA and RNA Banking Services market to expand 74% between 2024 and 2034.
dna and rna banking services market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032

Opportunities in the DNA and RNA Banking Services

The realm of DNA and RNA storage is always. Changing as technology advances play a significant part in its development. Cutting edge improvements, like automated handling of samples and cutting edge sequencing methods are improving the effectiveness and precision of DNA and RNA storage services. Enterprises that invest in these technologies can secure an advantage and fuel market expansion.

Growth Opportunities in North America and Asia-Pacific

North America Outlook

North America, with its advanced biotechnology infrastructure and substantial investment in research and development, is a key region for DNA and RNA Banking Services. The growth in this region is primarily driven by the increasing demand for personalized medicine, genetic research, and drug discovery. The presence of major players in the region, such as Thermo Fisher Scientific and Brooks Life Sciences, intensifies the competition, but also presents opportunities for collaboration and innovation. The regions robust regulatory framework also supports the growth of DNA and RNA banking services, ensuring the quality and safety of stored samples.

Asia-Pacific Outlook

The Asia-Pacific region is emerging as a significant player in the DNA and RNA Banking Services market. The growth here is fueled by increasing government support for biotechnology research, a rising number of genomics projects, and a growing awareness of personalized medicine. Countries like China and India are leading the way, with numerous startups entering the field, increasing the competition and driving innovation. Moreover, the expanding healthcare sector and the growing prevalence of genetic disorders in the region are further propelling the demand for DNA and RNA banking services.

Market Dynamics and Supply Chain

01

Driver: Advancements in Genomic Research, and Expansion of Personalized Medicine

The recent progress in studies has also greatly increased the need, for DNA and RNA storage services as scientists work towards unraveling the mysteries of the human genome more effectively; the importance of secure and efficient genetic material storage has also become crucial in this pursuit. This of service not only guarantees the preservation of important DNA and RNA samples but also simplifies their retrieval for later research endeavors—ultimately fueling market expansion. Personalized medicine, which tailors treatment to an individuals unique genetic makeup, is also another key for the DNA and RNA banking services market. As this field continues to expand, the need for secure and efficient storage of genetic material is also becoming increasingly important. DNA and RNA banking services are also vital in this regard, providing the necessary infrastructure for the development and implementation of personalized treatment plans.
The rising occurrence of disorders on a global scale is also a significant factor contributing to the growth of the DNA and RNA banking services industry market sector. These vital services are also essential in identifying and managing genetic conditions ranging from prevalent ailments such as cystic fibrosis to more uncommon diseases. With the efforts of the worldwide healthcare community in addressing these issues head on there is also an anticipated increase in the need, for top notch DNA and RNA banking services.
02

Restraint: High Cost of Services

The price of DNA and RNA storage services might be too expensive for a lot of people in them. These services require technologies and procedures like DNA extraction and storage which can cost a pretty penny. This steep price tag could discourage customers, like individuals or small research organizations from using these services and slow down market expansion.
03

Opportunity: Strategic Collaborations and Expansion into Untapped Markets

Collaborations that strategically unite DNA and RNA banking services with research institutions or pharmaceutical companies have the potential to create opportunities for expansion in the field. With these partnerships in place support, in terms of resource sharing and expertise exchange is facilitated, resultantly contributing to the advancement of sophisticated and effective DNA and RNA banking services. Additionally such collaborations may aid in broadening the customer reach and improving market presence.
The market for DNA and RNA banking services is experiencing expansion in developed nations but holds immense untapped possibilities in developing regions where awareness and availability of such services remain restricted stills. To unleash growth potential in DNA and RNA banking services industry lies in targeting these emerging markets by educating the public about the significance and advantages of these services and, by enhancing their accessibility and affordability.
04

Challenge: Regulatory Challenges

The DNA and RNA banking services industry is heavily regulated, with stringent guidelines and requirements for the collection, storage, and use of genetic material. These regulations vary by country and can be difficult for service providers to navigate, potentially leading to delays or increased costs. This complexity and uncertainty can discourage potential clients and limit the expansion of the market.

Supply Chain Landscape

1
Sample Collection & Preservation

Thermo Fisher Scientific

QIAGEN

2
Extraction & Purification

Illumina Inc

Agilent Technologies

3
Storage & Banking

BioStorage Technologies

Brooks Life Sciences

4
Analysis & Reporting

BGI Genomics

Genewiz

*The illustration highlights the key stakeholders within the supply chain ecosystem.

Applications of DNA and RNA Banking Services in Genomic Research, Forensic Science & Personalized Medicine

Genomic Research

DNA and RNA banking services play a pivotal role in genomic research. These services provide secure storage and preservation of valuable genetic material, enabling researchers to access and study this material whenever required. Top players in this application include GenBank and European Nucleotide Archive, both renowned for their extensive genomic databases and robust storage facilities. Their strength lies in their ability to provide high-quality, well-preserved genetic material for research, thereby strengthening their market position.

Forensic Science

In the field of forensic science, DNA and RNA banking services are essential for storing genetic evidence. This evidence can be used in criminal investigations and legal proceedings. Services such as Promega and Thermo Fisher Scientific are leading the way, offering secure, reliable storage solutions for forensic samples. Their market position is bolstered by their ability to provide services that ensure the integrity and longevity of stored genetic material.

Personalized Medicine

Personalized medicine is another region where DNA and RNA banking services are widely used. These services store patients genetic information, which can be used to tailor treatments to an individuals specific genetic makeup. Companies like Illumina and 23andMe are dominant in this field, offering services that enable the storage and analysis of genetic data for personalized healthcare. Their strengths include their advanced genetic analysis capabilities and their commitment to data security, solidifying their market position.

Recent Developments

December 2024

Biogenix Labs expanded their DNA and RNA Banking Services to include advanced genomics analysis, offering a comprehensive solution for researchers and clinicians alike

October 2024

GeneVault Inc. launched a state-of-the-art facility for DNA and RNA banking, promising superior preservation techniques and enhanced data security

August 2024

LifeBank Technologies introduced a novel RNA stabilization method in their banking services, significantly improving the longevity and integrity of stored RNA samples.

The DNA and RNA Banking Services industry has been experiencing significant growth due to advancements in biotechnology and the increasing demand for genetic research. The market has seen the emergence of several key players, each offering unique solutions to cater to the diverse needs of researchers and healthcare professionals worldwide. One of the most notable trends is the growing emphasis on personalized medicine.

Impact of Industry Transitions on the DNA and RNA Banking Services Market

As a core segment of the Biotechnology industry, the DNA and RNA Banking Services market develops in line with broader industry shifts. Over recent years, transitions such as Technological Advancements and Regulatory Changes have redefined priorities across the Biotechnology sector, influencing how the DNA and RNA Banking Services market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Technological Advancements

The DNA and RNA Banking Services industry has witnessed significant transitions due to technological advancements. The incorporation of high-throughput sequencing technologies and automated sample storage systems has revolutionized the sector. These advancements have improved the efficiency and accuracy of DNA and RNA banking, enabling the storage of larger sample volumes and ensuring the integrity of genetic material. This has had a profound impact on associated industries such as pharmaceuticals and biotechnology, where reliable and efficient genetic material storage is crucial for research and development activities. This industry transition is expected to add $800 million in the industry revenue between 2024 and 2030.
02

Regulatory Changes

The DNA and RNA Banking Services industry has also been shaped by regulatory changes. Governments worldwide have introduced stricter regulations to ensure the ethical collection, storage, and use of genetic material. These regulations have necessitated the implementation of robust data management systems and stringent quality control measures in DNA and RNA banks. This has influenced associated industries such as healthcare and forensics, where the legal and ethical use of genetic material is paramount.

Related Reports

Loading related reports...